News Brief: Genius Grant for Younger AD Researchers
Bright young stars, listen up...
6377 RESULTS
Sort By:
Bright young stars, listen up...
Washington: Alzhemed Non-story Yields Spotlight to Phase 2 Treatments Washington: Shaking Up AD Treatment with Ketone Bodies Washington: Site-to-Site Differences Delay Result of Alzhemed Trial Washington: γ-secretase Inhibitor Survived Phase 2, Moving to
For most people in AD research, a conference is the best place to...
At the second Alzheimer’s Association International Conference on Prevention...
To borrow a Twainism, news about the death of γ-secretase inhibitors proves to have been exaggerated...
A novel therapeutic approach captured some attention...
Physical and psychological stress can have long-lasting effects on the brain and even...
It is widely recognized that chronic stress—be it psychological or physical—is bad for one’s health. Yet...
Results from a mouse model of chronic neuroinflammation suggest that...
The apolipoprotein E4 allele (ApoE4) is the most prominent genetic risk factor for late-onset Alzheimer disease (LOAD), but it is not the whole story...
For years, rats have been the creature of choice for students of learning and behavior, as well as in pharmacology. Yet...
The striatum does not have a place of notoriety in Alzheimer disease research...
Kinases generally perform the quintessential job of substrate phosphorylation...
The microtubule-associated protein tau is a highly soluble protein that...
Last Wednesday, the Japanese film <em>Memories of Tomorrow</em> premiered in Los Angeles, California...